IBDEI2OR ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45072,1,4,0)
 ;;=4^D86.3
 ;;^UTILITY(U,$J,358.3,45072,2)
 ;;=^5002445
 ;;^UTILITY(U,$J,358.3,45073,0)
 ;;=D86.81^^200^2238^41
 ;;^UTILITY(U,$J,358.3,45073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45073,1,3,0)
 ;;=3^Sarcoid Meningitis
 ;;^UTILITY(U,$J,358.3,45073,1,4,0)
 ;;=4^D86.81
 ;;^UTILITY(U,$J,358.3,45073,2)
 ;;=^5002446
 ;;^UTILITY(U,$J,358.3,45074,0)
 ;;=D86.82^^200^2238^50
 ;;^UTILITY(U,$J,358.3,45074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45074,1,3,0)
 ;;=3^Sarcoidosis,Multiple Cranial Nerve Palsies
 ;;^UTILITY(U,$J,358.3,45074,1,4,0)
 ;;=4^D86.82
 ;;^UTILITY(U,$J,358.3,45074,2)
 ;;=^5002447
 ;;^UTILITY(U,$J,358.3,45075,0)
 ;;=D86.84^^200^2238^44
 ;;^UTILITY(U,$J,358.3,45075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45075,1,3,0)
 ;;=3^Sarcoid Pyelonephritis
 ;;^UTILITY(U,$J,358.3,45075,1,4,0)
 ;;=4^D86.84
 ;;^UTILITY(U,$J,358.3,45075,2)
 ;;=^5002449
 ;;^UTILITY(U,$J,358.3,45076,0)
 ;;=D86.85^^200^2238^42
 ;;^UTILITY(U,$J,358.3,45076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45076,1,3,0)
 ;;=3^Sarcoid Myocarditis
 ;;^UTILITY(U,$J,358.3,45076,1,4,0)
 ;;=4^D86.85
 ;;^UTILITY(U,$J,358.3,45076,2)
 ;;=^5002450
 ;;^UTILITY(U,$J,358.3,45077,0)
 ;;=D86.83^^200^2238^40
 ;;^UTILITY(U,$J,358.3,45077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45077,1,3,0)
 ;;=3^Sarcoid Iridocyclitis
 ;;^UTILITY(U,$J,358.3,45077,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,45077,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,45078,0)
 ;;=D84.1^^200^2238^16
 ;;^UTILITY(U,$J,358.3,45078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45078,1,3,0)
 ;;=3^Defects in Complement System
 ;;^UTILITY(U,$J,358.3,45078,1,4,0)
 ;;=4^D84.1
 ;;^UTILITY(U,$J,358.3,45078,2)
 ;;=^5002439
 ;;^UTILITY(U,$J,358.3,45079,0)
 ;;=D81.810^^200^2238^5
 ;;^UTILITY(U,$J,358.3,45079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45079,1,3,0)
 ;;=3^Biotinidase Deficiency
 ;;^UTILITY(U,$J,358.3,45079,1,4,0)
 ;;=4^D81.810
 ;;^UTILITY(U,$J,358.3,45079,2)
 ;;=^5002422
 ;;^UTILITY(U,$J,358.3,45080,0)
 ;;=E88.01^^200^2238^2
 ;;^UTILITY(U,$J,358.3,45080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45080,1,3,0)
 ;;=3^Apha-1 Antitrypsin Deficiency
 ;;^UTILITY(U,$J,358.3,45080,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,45080,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,45081,0)
 ;;=J09.X1^^200^2238^25
 ;;^UTILITY(U,$J,358.3,45081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45081,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
 ;;^UTILITY(U,$J,358.3,45081,1,4,0)
 ;;=4^J09.X1
 ;;^UTILITY(U,$J,358.3,45081,2)
 ;;=^5008144
 ;;^UTILITY(U,$J,358.3,45082,0)
 ;;=J09.X2^^200^2238^26
 ;;^UTILITY(U,$J,358.3,45082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45082,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Resp Manifest
 ;;^UTILITY(U,$J,358.3,45082,1,4,0)
 ;;=4^J09.X2
 ;;^UTILITY(U,$J,358.3,45082,2)
 ;;=^5008145
 ;;^UTILITY(U,$J,358.3,45083,0)
 ;;=J09.X3^^200^2238^27
 ;;^UTILITY(U,$J,358.3,45083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45083,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ GI Manifest
 ;;^UTILITY(U,$J,358.3,45083,1,4,0)
 ;;=4^J09.X3
 ;;^UTILITY(U,$J,358.3,45083,2)
 ;;=^5008146
 ;;^UTILITY(U,$J,358.3,45084,0)
 ;;=J09.X9^^200^2238^28
 ;;^UTILITY(U,$J,358.3,45084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45084,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Oth Manifest
 ;;^UTILITY(U,$J,358.3,45084,1,4,0)
 ;;=4^J09.X9
 ;;^UTILITY(U,$J,358.3,45084,2)
 ;;=^5008147
 ;;^UTILITY(U,$J,358.3,45085,0)
 ;;=J44.9^^200^2238^14
 ;;^UTILITY(U,$J,358.3,45085,1,0)
 ;;=^358.31IA^4^2
